Biodesix Inc (BDSX) income statement
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$8.40−0.48 (-5.41%)
Close on Nov 18, 2026Market cap $88.63MP/E –Yield –
Biodesix Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -20.0%
- Net margin
- -27.0%
- Return on equity, FY2025
- -383.1%
Financial strength
- Current ratio
- 2.85
- Debt to equity
- 5.12
- Debt to assets
- 49.1%
- Cash to current liabilities
- 196.2%
Valuation
- P/E ratio
- –
- Price to sales
- 0.86
- Price to book
- 9.69
- Dividend yield
- –
See a number that looks wrong?